The Pharmaceutical care of patients with type 2 diabetes mellitus

ISSN： 0928-1231

Source： Pharmacy World and Science, Vol.32, Iss.6, 2010-12, pp. : 730-736

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Shared vs outpatient care for type 2 diabetes mellitus

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 322, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Effect of CYP2C9 polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with Type 2 diabetes mellitus

By Swen Jesse J Wessels Judith AM Krabben Annemarie Assendelft Willem JJ Guchelaar Henk-Jan

Pharmacogenomics, Vol. 11, Iss. 11, 2010-11 ,pp. : 1517-1523

Future Medicine

Access to resources Recommend Favorite

A Real-World Analysis of Persistence on and Adherence to Glipizide GITS, Glipizide IR and Glibenclamide in Managed Care among Patients with Type 2 Diabetes Mellitus

By Harley C.R.

Clinical Drug Investigation, Vol. 22, Iss. 9, 2002-01 ,pp. : 575-584

Adis International

Access to resources Recommend Favorite

Postmarketing Surveillance of Acarbose Treatment in Taiwanese Patients with Type 2 Diabetes Mellitus

By Hung Yi-Jen

Clinical Drug Investigation, Vol. 26, Iss. 10, 2006-01 ,pp. : 559-565

Adis International

Access to resources Recommend Favorite

Pioglitazone is Effective Therapy for Elderly Patients with Type 2 Diabetes Mellitus

By Rajagopalan R. Perez A. Ye Z. Khan M. Murray F.T.

Drugs & Aging, Vol. 21, Iss. 4, 2004-01 ,pp. : 259-271

Adis International

Access to resources Recommend Favorite